Eeva K Broberg
Overview
Explore the profile of Eeva K Broberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heimsch K, Stanoeva K, Mogling R, Kraus A, Broberg E, Drexler J, et al.
J Clin Microbiol
. 2025 Mar;
:e0153824.
PMID: 40084838
The COVID-19 pandemic highlighted the importance of laboratory preparedness. Regular monitoring of diagnostic tools via external quality assessments (EQAs) is key to maintaining robust public health response service. We hereby...
2.
Vukovikj M, Melidou A, Nannapaneni P, Normark T, Kraus A, Broberg E
Euro Surveill
. 2025 Mar;
30(10).
PMID: 40084420
BackgroundMonoclonal antibodies (mAbs) and antiviral drugs have emerged as additional tools for treatment of COVID-19.AimWe aimed to review data on susceptibility of 14 SARS-CoV-2 variants to mAbs and antiviral drugs...
3.
Broberg E, Vukovikj M, Svartstrom O, Hasibra I, Riess M, Melidou A
Euro Surveill
. 2024 Dec;
29(50.
PMID: 39668766
BackgroundDuring the 2023/24 influenza season in the European Union/European Economic Area (EU/EEA), influenza viruses A(H1N1)pdm09, A(H3N2) and B/Victoria viruses were co-circulating.AimWe aimed to describe the circulating influenza viruses by (sub)type,...
4.
Broberg E, Svartstrom O, Riess M, Kraus A, Vukovikj M, Melidou A
Euro Surveill
. 2024 Sep;
29(39).
PMID: 39328158
BackgroundInfluenza viruses can cause large seasonal epidemics with high healthcare impact and severity as they continually change their virological properties such as genetic makeup over time.AimWe aimed to monitor the...
5.
Bubba L, Broberg E, Fischer T, Simmonds P, Harvala H
Emerg Infect Dis
. 2024 Jan;
30(2):234-244.
PMID: 38270192
Parechovirus infections usually affect neonates and young children; manifestations vary from asymptomatic to life-threatening. We describe laboratory capacity in Europe for assessing parechovirus circulation, seasonality, and epidemiology. We used retrospective...
6.
7.
Vaughan A, Duffell E, Freidl G, Lemos D, Nardone A, Valenciano M, et al.
BMJ Open
. 2023 Nov;
13(11):e064240.
PMID: 37931969
Objectives: Systematic review of SARS-CoV-2 seroprevalence studies undertaken in the WHO European Region to measure pre-existing and cumulative seropositivity prior to the roll out of vaccination programmes. Design: A systematic...
8.
Mogling R, Reimerink J, Stanoeva K, Keramarou M, Guiomar R, Costa I, et al.
J Virol Methods
. 2023 Oct;
322:114825.
PMID: 37778539
One consequence of the ongoing coronavirus disease pandemic was the rapid development of both in-house and commercial serological assays detecting anti-SARS-CoV-2 antibodies, in an effort to reliably detect acute and...
9.
Teirlinck A, Johannesen C, Broberg E, Penttinen P, Campbell H, Nair H, et al.
Eur Respir J
. 2023 Apr;
61(4).
PMID: 37012081
No abstract available.
10.
Li Y, Wang X, Broberg E, Campbell H, Nair H
Euro Surveill
. 2022 Apr;
27(16).
PMID: 35451364
BackgroundRespiratory syncytial virus (RSV) is the predominant cause of clinical pneumonia among infants and young children, often peaking during the winter months in temperate regions.AimTo describe RSV seasonality in 13...